Today the U.S. Advisory Committee on Immunization Practices recommended use of 2024-2025 Formula for COVID-19 vaccines authorized or approved by the U.S. FDA. Novavax has submitted its application to the U.S. FDA and, if authorized, expects to deliver the COVID-19 option in the U.S. Read the statement at: https://lnkd.in/ehyAU3ps
Exciting news from Novavax!
Novavax has filed with the European Medicines Agency (EMA) for a type II variation of its existing Marketing Authorization for its updated COVID-19 vaccine. Read the press release at: https://lnkd.in/dfizvc-2
Novavax is attending McKesson's ideaShare in New Orleans, LA this week. Attendees can connect with Lori Kinjorski, Director, Trade and Distribution and Michael Mulvey, Senior Director, National Accounts Retail, at this event dedicated to pushing pharmacy forward.
Join us in celebrating #Juneteenth, an important day of freedom and equality in the United States. Equity and inclusion are important parts of our workplace, and our quest to help protect public health.
Happy #FathersDay! A special shout out to all the fathers at Novavax who help make our innovative science possible. Hear from Tayo Bewaji, Manufacturing Manager, Jared Lantzy, PMP, Executive Director, Global Regulatory Operations, and Farai Michael Sikipa, Associate Director, Global Digital Planning and Performance Analytics, on what it means to be a Dad and #SuperNova.
Novavax has submitted its application to the U.S. FDA for its updated COVID-19 vaccine. If authorized, Novavax expects to be ready to deliver the only protein-based COVID-19 option in the U.S. in September. Read the press release at: https://lnkd.in/esxGEpYk
Ready to join our #SuperNova team? Explore opportunities: https://lnkd.in/e6cW9yxb
Today kicks off #NationalMensHealthWeek! How will you take time to prioritize your health?
Managing Director at CORPLEX IBERIA
1wGood to know!